Edgestream Partners, L.P. Novo Cure LTD Transaction History
Edgestream Partners, L.P.
- $2.23 Billion
- Q3 2024
A detailed history of Edgestream Partners, L.P. transactions in Novo Cure LTD stock. As of the latest transaction made, Edgestream Partners, L.P. holds 115,929 shares of NVCR stock, worth $3.18 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
115,929Holding current value
$3.18 Million% of portfolio
0.08%Shares
4 transactions
Others Institutions Holding NVCR
# of Institutions
262Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$333 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$325 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$217 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$118 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$83.2 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.88B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...